Nobelpharma

Patent cliffs & loss of exclusivity

Small Molecules

Company

Company Operating StatusActive
Official Websitehttp://nobelpharma.co.jp/en

1 upcoming patent cliff

DrugIngredientTypeCliff
  1. HYFTORSIROLIMUSSmall mol.Mar 2029

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Nobelpharma — patent cliffs & loss of exclusivity | CliffBio